Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy

@article{Watanabe2009ExpressionOX,
  title={Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy},
  author={Shin‐ichi Watanabe and Yasuyoshi Miyata and Shigeru Kanda and Takahisa Iwata and Tomayoshi Hayashi and Hiroshi Kanetake and Hideki Sakai},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2009},
  volume={136},
  pages={787-793}
}
PurposeX-linked inhibitor of apoptosis (XIAP) has high affinity and strong inhibitory activity on apoptosis-related caspase-3. The relationships between expression of XIAP and cleaved caspase-3, and response to neo-adjuvant hormonal therapy (NHT) remain elusive. The aim was to investigate whether NHT influences with XIAP expression in prostate cancer patients. In addition, the relationship between XIAP expression and apoptosis in patients who did or did not receive NHT was also investigated… 

Original Article High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma

TLDR
Twin plays important roles in tumor growth, progression, and survival in patients with RCC patients, and pathological mechanisms are significantly associated with increased cancer cell proliferation, angiogenesis, MMP2 expression, and macrophage recruitment.

Title High expression of Twist is associated with tumor aggressiveness and poorprognosis in patients with renal cell carcinoma

TLDR
Twin plays important roles in tumor growth, progression, and survival in patients with RCC patients and its pathological mechanisms are significantly associated with increased cancer cell proliferation, angiogenesis, MMP2 expression, and macrophage recruitment.

High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.

  • K. OhbaY. Miyata H. Sakai
  • Medicine, Biology
    International journal of clinical and experimental pathology
  • 2014
TLDR
Twin plays important roles in tumor growth, progression, and survival in patients with RCC patients and its pathological mechanisms are significantly associated with increased cancer cell proliferation, angiogenesis, MMP2 expression, and macrophage recruitment.

Phenethyl Isothiocyanate Sensitizes Androgen-Independent Human Prostate Cancer Cells to Docetaxel-Induced Apoptosis In Vitro and In Vivo

TLDR
The PEITC and/or Docetaxel-mediated changes in the levels of apoptosis regulating proteins in the tumor were generally consistent with the molecular alterations observed in cultured cells, and offer obligatory impetus to testPEITC-Docetaxe combination for the treatment of AIPC in a clinical setting.

Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival.

TLDR
It is suggested that low Fer expression in stromal cells is associated with increased malignant aggressiveness and decreased survival in patients with RCC.

Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a useful predictor of survival

TLDR
It is suggested that low Fer expression in stromal cells is associated with increased malignant aggressiveness and decreased survival in patients with RCC.

Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model

TLDR
Findings indicate that feeding with the addition of EP1 receptor antagonist delayed PC progression via the upregulation of apoptosis and suggest that the EP1 receptors antagonist may be a novel chemopreventive agent for PC.

Pathological Roles of Prostaglandin E2-specific E-type Prostanoid Receptors in Hormone-sensitive and Castration-resistant Prostate Cancer

TLDR
EP4R expression in CRPC was significantly higher than that in HSPC and was associated with cancer cell proliferation, apoptosis, and pro-angiogenetic potential.

Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer

TLDR
The co-expression of SSEA-4 in cancer cells and TICs may have crucial roles in the malignant aggressiveness and prognosis of PC and the combination was an independent predictor for pT3 and BCR in multivariate analysis.

Role of nm23H1 in predicting metastases in prostatic carcinoma

TLDR
IHC expression of nm23H1 is not an effective tool to distinguish among the cases of BPH, adenocarcinoma of prostate with and without metastasis, Hence nm23h1 gene does not behave like an antimetastatic gene in prostatic lesions.

References

SHOWING 1-10 OF 38 REFERENCES

Elevated expression of inhibitor of apoptosis proteins in prostate cancer.

TLDR
It is demonstrated that tumor- associated elevations in the expression of several IAP family proteins occur as a frequent and early event in the etiology of prostate cancer.

Loss of caspase-1 and caspase-3 protein expression in human prostate cancer.

TLDR
The loss of caspase-1 protein is implicate as a potential step in the loss of apoptotic control during prostate tumorigenesis and is suggested to have prognostic significance in disease progression.

Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line.

TLDR
It is suggested that finasteride induces apoptosis in LNCaP cells via proteins of the Bcl-2 and caspase family.

Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers

TLDR
Immunohistochemical assays directed at detection of certain combinations of apoptosis proteins may provide prognostic information for patients with early-stage colorectal cancer, and therefore could help to identify patients who might benefit from adjuvant chemotherapy or who should be spared it.

Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

TLDR
Reducing XIAP protein expression by either RNAi or antisense approaches increases cancer cell susceptibility to functionally diverse chemotherapeutic agents and supports the notion that downregulation of XIAP in vivo may synergize with disease-relevant chemtherapeutic regimes, including TRAIL and taxanes, to increase the effectiveness of antineoplastic agents.

Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines

TLDR
Understanding into how bicalutamide exerts its effects in androgen-independent cells will yield further insights into the treatment of hormone-refractory disease.

Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis

TLDR
AEG35156 reduces XIAP levels and sensitizes tumors to chemotherapy and is presently under clinical assessment in multiple phase I trials in cancer patients as a single agent and in combination with docetaxel in solid tumors or cytarabine/idarubicin in leukemia.

The inhibitors of apoptosis (IAPs) as cancer targets

TLDR
This review addresses IAP proteins as therapeutic targets for the treatment of cancer and emphasizes the importance of novel therapeutic approaches for cancer therapy.